Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 24330 | 316 | 38.0 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 613 | 3 | GOUT//HYPERURICEMIA//URIC ACID | 14056 |
| 2237 | 2 | HYPOPHOSPHATASIA//CD24//GLYCOSYLPHOSPHATIDYLINOSITOL | 4757 |
| 24330 | 1 | CD24//HEAT STABLE ANTIGEN//INTEGRATED CANC PREVENT | 316 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CD24 | authKW | 6136273 | 41% | 50% | 128 |
| 2 | HEAT STABLE ANTIGEN | authKW | 556764 | 3% | 52% | 11 |
| 3 | INTEGRATED CANC PREVENT | address | 315076 | 5% | 22% | 15 |
| 4 | CD24 GENE | authKW | 217417 | 1% | 75% | 3 |
| 5 | CD24 ANTIGEN | authKW | 193261 | 1% | 100% | 2 |
| 6 | MOUSE CD24 | authKW | 193261 | 1% | 100% | 2 |
| 7 | AB 2 CLONE SN3B | authKW | 96630 | 0% | 100% | 1 |
| 8 | ADRESSIN | authKW | 96630 | 0% | 100% | 1 |
| 9 | CD24 AND VEGF | authKW | 96630 | 0% | 100% | 1 |
| 10 | CD24 EXPRESSION | authKW | 96630 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 1046 | 31% | 0% | 97 |
| 2 | Immunology | 666 | 23% | 0% | 73 |
| 3 | Pathology | 231 | 8% | 0% | 26 |
| 4 | Medicine, Research & Experimental | 162 | 9% | 0% | 30 |
| 5 | Cell Biology | 126 | 12% | 0% | 38 |
| 6 | Gastroenterology & Hepatology | 54 | 5% | 0% | 15 |
| 7 | Biochemistry & Molecular Biology | 29 | 13% | 0% | 40 |
| 8 | Biotechnology & Applied Microbiology | 18 | 5% | 0% | 15 |
| 9 | Biophysics | 13 | 3% | 0% | 11 |
| 10 | Cell & Tissue Engineering | 11 | 1% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTEGRATED CANC PREVENT | 315076 | 5% | 22% | 15 |
| 2 | CHINESE MINIST EDUC CARCINOGENESIS CANC | 96630 | 0% | 100% | 1 |
| 3 | COLD OCEAN | 96630 | 0% | 100% | 1 |
| 4 | D010 | 96630 | 0% | 100% | 1 |
| 5 | DEEP SEA IL | 96630 | 0% | 100% | 1 |
| 6 | DEP ANAT PATHOL | 96630 | 0% | 100% | 1 |
| 7 | DIAG TREATMENT TECHNOL THORAC ONCOL LUN | 96630 | 0% | 100% | 1 |
| 8 | GI STATE ONCOGENE RELATED GENES | 96630 | 0% | 100% | 1 |
| 9 | MITRA BIOTECH PVT LTD | 96630 | 0% | 100% | 1 |
| 10 | MOL MECHANISMS ORIGINS | 96630 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1714 | 1% | 0% | 4 |
| 2 | PATHOLOGY & ONCOLOGY RESEARCH | 677 | 1% | 0% | 3 |
| 3 | EUROPEAN JOURNAL OF IMMUNOLOGY | 583 | 3% | 0% | 9 |
| 4 | JOURNAL OF EXPERIMENTAL MEDICINE | 493 | 3% | 0% | 8 |
| 5 | JOURNAL OF MOLECULAR HISTOLOGY | 477 | 1% | 0% | 2 |
| 6 | CANCER GENOMICS & PROTEOMICS | 458 | 0% | 0% | 1 |
| 7 | JOURNAL OF IMMUNOLOGY | 441 | 5% | 0% | 16 |
| 8 | ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY | 415 | 0% | 0% | 1 |
| 9 | VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 360 | 0% | 0% | 1 |
| 10 | AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 352 | 1% | 0% | 2 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CD24 | 6136273 | 41% | 50% | 128 | Search CD24 | Search CD24 |
| 2 | HEAT STABLE ANTIGEN | 556764 | 3% | 52% | 11 | Search HEAT+STABLE+ANTIGEN | Search HEAT+STABLE+ANTIGEN |
| 3 | CD24 GENE | 217417 | 1% | 75% | 3 | Search CD24+GENE | Search CD24+GENE |
| 4 | CD24 ANTIGEN | 193261 | 1% | 100% | 2 | Search CD24+ANTIGEN | Search CD24+ANTIGEN |
| 5 | MOUSE CD24 | 193261 | 1% | 100% | 2 | Search MOUSE+CD24 | Search MOUSE+CD24 |
| 6 | AB 2 CLONE SN3B | 96630 | 0% | 100% | 1 | Search AB+2+CLONE+SN3B | Search AB+2+CLONE+SN3B |
| 7 | ADRESSIN | 96630 | 0% | 100% | 1 | Search ADRESSIN | Search ADRESSIN |
| 8 | CD24 AND VEGF | 96630 | 0% | 100% | 1 | Search CD24+AND+VEGF | Search CD24+AND+VEGF |
| 9 | CD24 EXPRESSION | 96630 | 0% | 100% | 1 | Search CD24+EXPRESSION | Search CD24+EXPRESSION |
| 10 | CD24 MRNA EXPRESSION | 96630 | 0% | 100% | 1 | Search CD24+MRNA+EXPRESSION | Search CD24+MRNA+EXPRESSION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | FANG, XF , ZHENG, P , TANG, J , LIU, Y , (2010) CD24: FROM A TO Z.CELLULAR & MOLECULAR IMMUNOLOGY. VOL. 7. ISSUE 2. P. 100-103 | 72 | 73% | 41 |
| 2 | TAN, YX , ZHAO, M , XIANG, B , CHANG, C , LU, QJ , (2016) CD24: FROM A HEMATOPOIETIC DIFFERENTIATION ANTIGEN TO A GENETIC RISK FACTOR FOR MULTIPLE AUTOIMMUNE DISEASES.CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. VOL. 50. ISSUE 1. P. 70 -83 | 66 | 51% | 3 |
| 3 | SADOT, E , KRAUS, S , STEIN, M , NABOISHCHIKOV, I , TOLEDANO, O , KAZANOV, D , ARBER, N , KASHTAN, H , (2014) CD24 GENE POLYMORPHISM - A NOVEL PROGNOSTIC FACTOR IN ESOPHAGEAL CANCER.INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. VOL. 29. ISSUE 1. P. E49 -E54 | 33 | 89% | 3 |
| 4 | MA, ZL , CHEN, YP , SONG, JL , WANG, YQ , (2015) KNOCKDOWN OF CD24 INHIBITS PROLIFERATION, INVASION AND SENSITIZES BREAST CANCER MCF-7 CELLS TO TAMOXIFEN IN VITRO.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. VOL. 19. ISSUE 13. P. 2394 -2399 | 25 | 96% | 4 |
| 5 | BRETZ, NP , SALNIKOV, AV , DOBERSTEIN, K , GARBI, N , KLOESS, V , JOUMAA, S , NAUMOV, I , BOON, L , MOLDENHAUER, G , ARBER, N , ET AL (2014) LACK OF CD24 EXPRESSION IN MICE REDUCES THE NUMBER OF LEUKOCYTES IN THE COLON.IMMUNOLOGY LETTERS. VOL. 161. ISSUE 1. P. 140 -148 | 26 | 74% | 2 |
| 6 | TAKAHASHI, M , NAKAJIMA, M , OGATA, H , DOMEKI, Y , OHTSUKA, K , IHARA, K , KURAYAMA, E , ONODERA, S , YAMAGUCHI, S , SASAKI, K , ET AL (2013) CD24 EXPRESSION IS ASSOCIATED WITH PROGRESSION OF GASTRIC CANCER.HEPATO-GASTROENTEROLOGY. VOL. 60. ISSUE 124. P. 653-658 | 24 | 77% | 9 |
| 7 | SANO, A , KATO, H , SAKURAI, S , SAKAI, M , TANAKA, N , INOSE, T , SAITO, K , SOHDA, M , NAKAJIMA, M , NAKAJIMA, T , ET AL (2009) CD24 EXPRESSION IS A NOVEL PROGNOSTIC FACTOR IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA.ANNALS OF SURGICAL ONCOLOGY. VOL. 16. ISSUE 2. P. 506 -514 | 30 | 65% | 39 |
| 8 | MARME, F , WERFT, W , WALTER, A , KELLER, S , WANG, XL , BENNER, A , BURWINKEL, B , SINN, P , HUG, S , SOHN, C , ET AL (2012) CD24 ALA57VAL POLYMORPHISM PREDICTS PATHOLOGIC COMPLETE RESPONSE TO SEQUENTIAL ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT CHEMOTHERAPY FOR PRIMARY BREAST CANCER.BREAST CANCER RESEARCH AND TREATMENT. VOL. 132. ISSUE 3. P. 819 -831 | 32 | 60% | 8 |
| 9 | LEE, JH , KIM, SH , LEE, ES , KIM, YS , (2009) CD24 OVEREXPRESSION IN CANCER DEVELOPMENT AND PROGRESSION: A META-ANALYSIS.ONCOLOGY REPORTS. VOL. 22. ISSUE 5. P. 1149-1156 | 27 | 73% | 34 |
| 10 | LEE, HJ , KIM, DI , KWAK, C , KU, JH , MOON, KC , (2008) EXPRESSION OF CD24 IN CLEAR CELL RENAL CELL CARCINOMA AND ITS PROGNOSTIC SIGNIFICANCE.UROLOGY. VOL. 72. ISSUE 3. P. 603-607 | 24 | 86% | 21 |
Classes with closest relation at Level 1 |